RICARDO PINEIRO HERNANDEZ: Open Payments
NPI 1225663172 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,738 in 84 payments from 25 companies in 2025. Trend: 2023 $445 · 2024 $1,067 · 2025 $1,738
Food & beverage: $1,738
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $241 |
| Medtronic, Inc. | 2 | $228 |
| Corcept Therapeutics | 9 | $157 |
| Insulet Corporation | 11 | $150 |
| Tandem Diabetes Care, Inc. | 4 | $148 |
| Novo Nordisk Inc | 14 | $140 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $116 |
| Lilly USA, LLC | 6 | $104 |
| Madrigal Pharmaceuticals | 3 | $66 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $48 |
Products named: MINIMED 780G, Korlym, AIRSUPRA, Omnipod, t:slim X2 Insulin Pump with Control-IQ, JARDIANCE, FARXIGA, MOUNJARO.
Industry payments across FL — which companies pay providers there.
